Toggle navigation
Browse
Home
Researchers
Research Departments
Publications
About/Support
JOURNAL OF PANCREATIC CANCER
Journal
Overview
Identity
Other
View All
Overview
publication venue for
A Phase 2 Randomized Placebo-Controlled Adjuvant Trial of GI-4000, a Recombinant Yeast Expressing Mutated RAS Proteins in Patients with Resected Pancreas Cancer
. 7:8-19.
2021
Safety Study of Targeted and Localized Intra-Arterial Delivery of Gemcitabine in Patients with Locally Advanced Pancreatic Adenocarcinoma
. 3:58-65.
2017
Identity
International Standard Serial Number (ISSN)
2475-3246
Electronic International Standard Serial Number (EISSN)
2475-3246
Other
journal abbreviation
J PANCREATIC CANCER